Advertisement

Search Results for "Superficial Gastrocnemius Vein Thrombosis"

18:46 EDT 21st May 2013 | BioPortfolio

Original Source: Management of isolated soleal and gastrocnemius vein thrombosis.

OBJECTIVE: The ideal treatment for hospitalized patients with isolated gastrocnemius and/or soleal venous thrombosis is unclear. Recommendations range from watchful waiting to full-dose anticoagulation. This study examines the effectiveness of practice patterns at a single institution as measured by progression of thrombus. METHODS: All consecutive inpatients with a duplex scan diagnosis of isolated gastrocnemius and/or soleal vein clot (no other thrombotic segments were identified) and where two consecutiv...

Matching Channels

Superficial Venous Thrombosis

Renal Vein Thrombosis

Venous Arterial Thromboembolism

Thrombosis is the formation of a blood clot inside a blood vessel, blocking a vein (venous thrombosis) or artery (arterial thrombosis). Venous Arterial Thromboembolism (VAT) is caused when some or a...

Thrombosis

Superficial cancers

Matching News

Asymptomatic deep vein thrombosis and superficial vein thrombosis in ambulatory cancer patients: impact on short-term survival

NICE yes for Xarelto to treat blood clots

NICE is recommending Bayer’s Xarelto (rivaroxaban) for the treatment and prevention of deep vein thrombosis (DVT). The watchdog said in its final guidance that Xarelto is now an option for treating...

NICE now backs Xarelto to treat blood clots; negative on Bronchitol for CF

In final draft guidance published today (1 June 1), UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) has recommended German drug major Bayer's (BAYN: DE) Xarelto (riv...

Long-term mortality risk low after cerebral vein thrombosis

(HealthDay) -- For patients who survive a cerebral vein thrombosis (CVT), the long-term risk of mortality and recurrent venous thromboembolism (VTE) seems to be low, according to a study published in...

UK NICE says final "yes" for Bayer's Xarelto to treat blood clots

Confirming its final draft guidance last month (The Pharma Letter June 1), in final guidance published today (July 25), the UK drugs watchdog the National Institute for Health and Clinical Excellence...

Gene offers new insights into treatment strategies for deep-vein thrombosis

A gene associated with both protection against bacterial infection and excessive blood clotting could offer new insights into treatment strategies for deep-vein thrombosis -- the formation of a harmfu...

Treatment Algorithm Helps To Rule Out Deep Vein Thrombosis At The Primary Care Level

Algorithms improve certainty in ruling out deep and pelvic vein thrombosis at the primary level of patient care, say Lobna El Tabei and her co-authors in the current issue of the Deutsches Arzteblatt...

Deep vein thrombosis (DVT): Blood-clotting disorder with dangerous complications

Deep vein thrombosis — Comprehensive overview covers symptoms, treatment, prevention of this blood-clotting disorder.

Matching PubMed Articles

Fondaparinux for the treatment of superficial-vein thrombosis in the legs.

BACKGROUND: The efficacy and safety of anticoagulant treatment for patients with acute, symptomatic superficial-vein thrombosis in the legs, but without concomitant deep-vein thrombosis or symptomatic...

Superficial venous thrombosis : A review.

This review summarizes the epidemiology, clinical aspects, diagnosis and new therapeutic options of the superficial venous thrombosis. An important new finding is, that the thrombophlebitis is actuall...

Treatment of Superficial Thrombophlebitis.

To the Editor: Decousus et al. (Sept. 23 issue)(1) report that fondaparinux was effective in the treatment of superficial-vein thrombosis, as compared with placebo. The authors state that hemostasis m...

Treatment of Superficial Thrombophlebitis.

To the Editor: Decousus et al. (Sept. 23 issue)(1) report that fondaparinux was effective in the treatment of superficial-vein thrombosis, as compared with placebo. The authors state that hemostasis m...

Treatment of Superficial Thrombophlebitis.

To the Editor: Decousus et al. (Sept. 23 issue)(1) report that fondaparinux was effective in the treatment of superficial-vein thrombosis, as compared with placebo. The authors state that hemostasis m...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement